VASO Corp Announces Executive and Director Changes

Ticker: VASO · Form: 8-K · Filed: Jan 3, 2025 · CIK: 839087

Vaso Corp 8-K Filing Summary
FieldDetail
CompanyVaso Corp (VASO)
Form Type8-K
Filed DateJan 3, 2025
Risk Levelmedium
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: management-change, corporate-governance

TL;DR

VASO Corp shakes up leadership on Jan 1, 2025 - new directors elected, exec comp updated.

AI Summary

VASO Corporation announced on January 1, 2025, changes in its executive and director positions. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its officers. Specific names and dollar amounts related to these changes were not detailed in the provided text.

Why It Matters

Changes in leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence and stock performance.

Risk Assessment

Risk Level: medium — Executive and director changes can introduce uncertainty about future strategy and operational stability.

Key Players & Entities

  • VASO Corporation (company) — Registrant
  • January 1, 2025 (date) — Date of earliest event reported

FAQ

What specific roles have been affected by the changes in officers and directors?

The filing indicates changes in 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers' but does not specify the exact roles in the provided text.

Were there any new directors elected to the board?

Yes, the filing lists 'Election of Directors' as an item of information, indicating new directors were elected.

Are there details on the new compensatory arrangements for officers?

The filing mentions 'Compensatory Arrangements of Certain Officers' but the specific details of these arrangements are not included in the provided text.

What is the exact date of the earliest event reported in this 8-K filing?

The earliest event reported is dated January 1, 2025.

What is VASO Corporation's Standard Industrial Classification (SIC) code?

VASO Corporation's SIC code is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.

Filing Stats: 514 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2025-01-03 16:08:23

Filing Documents

02. Departure of Directors or Certain Officers; Election

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) & (c) Effective January 1, 2025, the Board of Directors appointed Jane Moen as its Chief Operating Officer. Mr. Peter C. Castle, previously Chief Operating Officer, will continue in his capacity as President of the Company's wholly-owned subsidiary, VasoTechnology, Inc. Ms. Moen, age 45, has been a director of the Company since March 2020 and an executive officer of the Company since 2018. Ms. Moen has been President of the Company's wholly-owned subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, since June 2018 and will continue in that capacity. Effective January 1, 2025, Michael Beecher, previously Co-Chief Financial Officer and Secretary, ceased serving in those roles but will continue to be employed by the Company as a financial advisor. As a result, Jonathan Newton, previously Co-Chief Financial Officer and Treasurer of the Company, continues as the company's sole Chief Financial Officer and Treasurer and was also appointed as the Secretary of the Company. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 3, 2025 VASO CORPORATION By: /s/ Jun Ma Name: Jun Ma Title: Chief Executive Officer and President 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.